Patents by Inventor Laurence R. Meyerson

Laurence R. Meyerson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method and Composition for Administering an NMDA Receptor Antagonist to a Subject
    Publication number: 20120046365
    Abstract: The invention provides methods and compositions for administering an NMDA receptor antagonist (e.g., memantine) to a subject.
    Type: Application
    Filed: October 28, 2011
    Publication date: February 23, 2012
    Applicant: Adamas Pharmaceuticals, Inc.
    Inventors: Gregory T. Went, Timothy J. Fultz, Seth Porter, Laurence R. Meyerson, Timothy S. Burkoth
  • Method and Composition for Administering an NMDA Receptor Antagonist to a Subject
    Publication number: 20110059169
    Abstract: The invention provides methods and compositions for administering an NMDA receptor antagonist (e.g., memantine) to a subject.
    Type: Application
    Filed: July 20, 2010
    Publication date: March 10, 2011
    Applicant: Adamas Pharmaceuticals, Inc.
    Inventors: Gregory T. Went, Timothy J. Fuitz, Seth Porter, Laurence R. Meyerson, Timothy S. Burkoth
  • Methods and Compositions for the Treatment of Psychiatric Conditions
    Publication number: 20100292216
    Abstract: This invention relates to methods and compositions for treating psychiatric conditions, such as depression.
    Type: Application
    Filed: November 16, 2009
    Publication date: November 18, 2010
    Applicant: ADAMAS PHARMACEUTICALS, INC.
    Inventors: Laurence R. Meyerson, Gregory T. Went, Timothy J. Fultz
  • METHOD AND COMPOSITION FOR ADMINISTERING AN NMDA RECEPTOR ANTAGONIST TO A SUBJECT
    Publication number: 20100266684
    Abstract: The invention provides methods and compositions for administering an NMDA receptor antagonist (e.g., memantine) to a subject.
    Type: Application
    Filed: April 9, 2010
    Publication date: October 21, 2010
    Applicant: Adamas Pharmaceuticals, Inc.
    Inventors: Gregory T. Went, Timothy J. Fultz, Seth Porter, Laurence R. Meyerson, Timothy S. Burkoth
  • METHOD AND COMPOSITION FOR ADMINISTERING AN NMDA RECEPTOR ANTAGONIST TO A SUBJECT
    Publication number: 20100260838
    Abstract: The invention provides methods and compositions for administering an NMDA receptor antagonist (e.g., memantine) to a subject.
    Type: Application
    Filed: April 9, 2010
    Publication date: October 14, 2010
    Applicant: Adamas Pharmaceuticals, Inc.
    Inventors: Gregory T. Went, Timothy J. Fultz, Seth Porter, Laurence R. Meyerson, Timothy S. Burkoth
  • Method and Composition for Administering an NMDA Receptor Antagonist to a Subject
    Publication number: 20100047342
    Abstract: The invention provides methods and compositions for administering an NMDA receptor antagonist (e.g., memantine) to a subject.
    Type: Application
    Filed: July 30, 2009
    Publication date: February 25, 2010
    Applicant: ADAMAS PHARMACEUTICALS, INC.
    Inventors: Gregory T. Went, Timothy J. Fultz, Seth Porter, Laurence R. Meyerson, Timothy S. Burkoth
  • Methods and Compositions for Treating Migraine Pain
    Publication number: 20100029665
    Abstract: The present invention provides novel methods and compositions for the treatment and prevention of headaches, vascular headaches, migraine headaches, cluster headaches, and migraine. One of the headaches, vascular headaches, migraine headaches, cluster headaches, and migraine treated by the methods and compositions of the invention is migraine.
    Type: Application
    Filed: April 8, 2009
    Publication date: February 4, 2010
    Inventors: Laurence R. Meyerson, Gregory T. Went, Timothy J. Fultz, Timothy S. Burkoth
  • Methods and Compositions for the Treatment of CNS-Related Conditions
    Publication number: 20100022659
    Abstract: The invention provides methods and compositions for the treatment of dementia-related conditions, such as Parkinson's disease and Alzheimer's disease.
    Type: Application
    Filed: June 24, 2009
    Publication date: January 28, 2010
    Inventors: Laurence R. Meyerson, Gregory T. Went, Timothy J. Fultz
  • Methods and compositions for the treatment of epilepsy, seizure disorders, and other CNS disorders
    Publication number: 20090306051
    Abstract: The present invention relates to methods and compositions for treating CNS-related disorders.
    Type: Application
    Filed: December 11, 2008
    Publication date: December 10, 2009
    Inventors: Laurence R. Meyerson, Gregory T. Went, Timothy J. Fultz
  • Method and composition for administering an NMDA receptor antagonist to a subject
    Patent number: 7619007
    Abstract: The invention provides methods and compositions for administering an NMDA receptor antagonist (e.g., memantine) to a subject.
    Type: Grant
    Filed: November 22, 2005
    Date of Patent: November 17, 2009
    Assignee: Adamas Pharmaceuticals, Inc.
    Inventors: Gregory T. Went, Timothy J. Fultz, Laurence R. Meyerson
  • Methods and Compositions for Treating Nociceptive Pain
    Publication number: 20090253728
    Abstract: The present invention provides methods and compositions useful for the treatment and prevention of pain.
    Type: Application
    Filed: September 30, 2008
    Publication date: October 8, 2009
    Inventors: Laurence R. Meyerson, Gregory T. Went, Timothy S. Burkoth
  • Treatment of Demyelinating Conditions
    Publication number: 20090234021
    Abstract: The present invention provides novel methods and compositions for the treatment of multiple sclerosis.
    Type: Application
    Filed: October 6, 2008
    Publication date: September 17, 2009
    Inventors: Stuart A. Lipton, Gregory T. Went, Laurence R. Meyerson
  • Combinations Therapy for Treatment of Demyelinating Conditions
    Publication number: 20080279819
    Abstract: The present invention provides novel methods and compositions for the treatment and prevention of demyelinating conditions. One demyelinating condition treated by the methods and compositions of the invention is multiple sclerosis. Also treated are symptoms associated with multiple sclerosis.
    Type: Application
    Filed: February 15, 2006
    Publication date: November 13, 2008
    Inventors: Gregory T. Went, Timothy J. Fultz, Laurence R. Meyerson, David Chernoff